Loading organizations...
BrueckenKoepfe Management operates as a concept and investment agency within the complex German healthcare sector, offering strategic guidance to foster the successful integration of innovation. The firm specializes in navigating intricate decision-making processes and understanding the diverse interests of various stakeholders, including medical professionals, political bodies, healthcare enterprises, and social institutions. Their technical approach centers on a "Triple P" focus: prevention, care, and patient orientation, ensuring that valuable advancements reach the healthcare and nursing supply chain effectively.
Jürgen Graalmann and Harm van Maanen lead BrueckenKoepfe, having identified a critical need for expertise in bridging the gap between novel ideas and their practical application in a highly regulated environment. Their insight stemmed from recognizing that many promising healthcare innovations often falter not due to lack of merit, but from insufficient understanding of systemic complexities and stakeholder alignment. The firm was established to provide the necessary strategic frameworks and operational support for these ventures.
The agency primarily serves innovators and emerging companies within health technology seeking to establish or expand their presence in the German healthcare landscape. BrueckenKoepfe's overarching vision is to generate substantial added value for health by ensuring that meaningful advancements in prevention, care, and patient-centric services are not only conceptualized but also successfully implemented, thereby improving overall health outcomes and efficiency within the system.
BrueckenKoepfe Management has 1 tracked investment across 1 company. The latest tracked deal is $17.3M Series A in anvajo in October 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 21, 2022 | anvajo | $17.3M Series A | — | Elber Beteiligungen, Johnsonville Holdings, Medice Arzneimittel, Think.health Ventures |